查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1615412

基因表现分析市场：按产品、应用和最终用户划分 - 2025-2030 年全球预测

Gene Expression Analysis Market by Offering (Instruments, Reagents & Consumables, Services), Application (Clinical Diagnostics, Drug Discovery & Development), End-user - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023 年，基因表现分析市值为 40 亿美元，预计到 2024 年将达到 43 亿美元，预计复合年增长率为 7.80%，到 2030 年将达到 67.7 亿美元。

基因表现分析检查基因在各种生物条件下的活性（表达），对于了解疾病、药物交互作用和发育过程至关重要。他们的需求源于其在个人化医疗中的关键作用，帮助识别疾病标记和治疗靶点，最终改善患者的治疗结果。应用范围涵盖肿瘤学、药物基因组学和农业生物技术，并用于实验室、製药公司和临床诊断。精准医疗需求的不断增长、测序技术的进步以及慢性病的增加推动了市场的成长。特别是，RNA-seq 和高通量微阵列技术的出现彻底改变了研究人员进行遗传分析的方式，实现了更全面的资料收集和分析。

主要市场统计
基准年[2023] 40亿美元
预测年份 [2024] 43亿美元
预测年份 [2030] 67.7亿美元
复合年增长率（%） 7.80%

然而，该市场受到先进平台的高成本和资料管理挑战（例如处理巨量资料时储存和解释的复杂性）的限制。严格的法律规范也会减慢创新和采用率。然而，开发具有成本效益的快速诊断工具，将人工智慧和机器学习整合起来进行资料分析，从而提高速度和准确性，并存在潜在的机会。开发简化资料解释的应用程式还可以弥合资料生成和临床应用之间的差距。这对于提高可推动个人化治疗的大型资料集的效用尤其重要。

基因编辑技术与表达分析相结合以及专注于单细胞RNA测序等创新领域为未来的成长带来了巨大的希望。此外，旨在透过基因表现见解提高作物抗性和产量的农业生物技术的新应用可能会使市场成长管道多样化。研究机构和技术开发商之间的合作对于推动产业进步至关重要。儘管面临挑战，公司可以透过专注于这些创新前沿并透过强有力的伙伴关係和研发投资来优化其技术采用策略，从而有效地利用未来的市场机会。

市场动态：快速发展的基因表现分析市场的关键市场洞察

供需的动态交互作用正在改变基因表现分析市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助企业了解消费行为及其对製造业的影响。

  • 市场驱动因素
    • 慢性病增加
    • 人们越来越偏好基于基因的诊断
    • 基因编辑技术、定序和生物资讯学不断进步
  • 市场限制因素
    • 技术纯熟劳工短缺、设备及用品相关成本；
  • 市场机会
    • 日益关注精准肿瘤学
    • 对个体化医疗的需求不断增加
  • 市场挑战
    • 对资料解释的担忧

波特五力：驾驭基因表现表现分析市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解基因表现分析市场的外部影响

外部宏观环境因素在塑造基因表现分析市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助企业预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解基因表现分析市场的竞争状况

基因表现分析市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵基因表现分析市场供应商绩效评估

FPNV定位矩阵是评估基因表现分析市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议绘製基因表现分析市场的成功之路

基因表现分析市场的策略分析对于旨在加强其在全球市场的影响力的公司至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 慢性病流行
      • 人们对基于基因的诊断越来越感兴趣
      • 基因编辑技术、定序和生物资讯学的进展
    • 抑制因素
      • 熟练劳动力的短缺以及与设备和用品相关的成本；
    • 机会
      • 精准肿瘤学受到越来越多的关注
      • 客製化医疗服务的需求不断增长
    • 任务
      • 对资料解释的担忧
  • 市场区隔分析
    • 我们提供什么：更多采用具有特异性和扩充性的先进设备
    • 应用：基因表现分析对于简化药物标靶辨识的重要性日益增加
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章基因表现分析市场：透过提供

  • 装置
    • 微阵列扫描仪
    • 次世代定序（NGS）平台
    • PCR
  • 试剂/耗材
    • 检测方法和套件
    • DNA微阵列
    • 酵素
  • 服务

第七章基因表现分析市场：依应用分类

  • 临床诊断
  • 药物发现与开发

第 8 章基因表现分析市场：依最终用户分类

  • 学术/研究机构
  • 诊断实验室
  • 製药和生物技术公司

第九章北美和南美基因表现分析市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第10章亚太地区基因表现分析市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲、中东和非洲的基因表现分析市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Thermo Fisher Scientific 推出 Invitrogen TaqMan Cells-to-CT Express 试剂套件以简化 RNA 处理。
    • Tempus 推出了 Tempus xR，独立的 RNA定序测试。
    • QIAGEN 推出增强版 QIAGEN CLC Genomics Workbench Premium
  • 战略分析和建议

公司名单

  • 10x Genomics
  • Agilent Technologies Inc.
  • Bio-Rad Laboratories Inc.
  • BioSpyder, Inc.
  • CD Genomics
  • Charles River Laboratories International, Inc.
  • Danaher Corporation
  • DiaSorin SpA
  • Eurofins Scientific SE
  • F. Hoffmann-La Roche Ltd.
  • Illumina Inc.
  • Inotiv, Inc.
  • LGC Limited
  • Merck KGaA
  • Meridian Bioscience, Inc.
  • NanoString Technologies Inc.
  • New England Biolab
  • Oxford Gene Technology IP Limited
  • Oxford Nanopore Technologies plc
  • Promega Corporation
  • QIAGEN NV
  • Revvity, Inc.
  • Standard BioTools
  • Takara Bio, Inc.
  • Thermo Fisher Scientific Inc
  • Zymo Research Corporation
Product Code: MRR-EA11B604F62B

The Gene Expression Analysis Market was valued at USD 4.00 billion in 2023, expected to reach USD 4.30 billion in 2024, and is projected to grow at a CAGR of 7.80%, to USD 6.77 billion by 2030.

Gene expression analysis involves examining the activity (expression) of genes in various biological conditions, making it integral to understanding diseases, drug interactions, and development processes. Its necessity arises from its pivotal role in personalized medicine, where it aids in identifying disease markers and therapeutic targets, ultimately improving patient outcomes. Applications span across oncology, pharmacogenomics, and agricultural biotechnology, with usage in research laboratories, pharmaceutical companies, and clinical diagnostics. Market growth is driven by increased demand for precision medicine, advancements in sequencing technologies, and rising incidences of chronic diseases. Particularly, the advent of RNA-seq and high-throughput microarray technologies has revolutionized how researchers approach genetic analyses, allowing more comprehensive data collection and analysis.

KEY MARKET STATISTICS
Base Year [2023] USD 4.00 billion
Estimated Year [2024] USD 4.30 billion
Forecast Year [2030] USD 6.77 billion
CAGR (%) 7.80%

However, the market is fraught with limitations like high costs of advanced platforms and data management challenges, including storage and interpretation complexities in handling big data. Stringent regulatory frameworks can also slow innovation and adoption rates. Yet, potential opportunities exist in developing cost-effective, rapid diagnostic tools that integrate AI and machine learning for data analysis, improving both speed and accuracy. Developing applications that streamline and simplify data interpretation can also bridge gaps between data generation and clinical application. This is particularly crucial in increasing the utility of large datasets, which can drive personalized therapies.

Innovative areas such as integrating gene editing technologies with expression analysis or focusing on single-cell RNA sequencing hold substantial promise for growth. Furthermore, novel applications in agricultural biotech, aiming to enhance crop resistance and yield through gene expression insights, can diversify market growth channels. Collaboration between research entities and tech developers will be vital for propelling industry advancements. Despite challenges, focusing on these innovative fronts and optimizing technology adoption strategies through strong partnerships and investment in R&D can position businesses to harness upcoming market opportunities efficiently.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Gene Expression Analysis Market

The Gene Expression Analysis Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising prevalence of chronic diseases
    • Increasing preference for gene-based diagnostics
    • Growing advancements in gene editing technology, sequencing, and bioinformatics
  • Market Restraints
    • Lack of skilled labor and expenses associated with the instruments and consumables
  • Market Opportunities
    • Increasing focus on precision oncology
    • Rising need for customized medicine
  • Market Challenges
    • Concerns associated with the interpretation of data

Porter's Five Forces: A Strategic Tool for Navigating the Gene Expression Analysis Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Gene Expression Analysis Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Gene Expression Analysis Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Gene Expression Analysis Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Gene Expression Analysis Market

A detailed market share analysis in the Gene Expression Analysis Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Gene Expression Analysis Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Gene Expression Analysis Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Gene Expression Analysis Market

A strategic analysis of the Gene Expression Analysis Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Gene Expression Analysis Market, highlighting leading vendors and their innovative profiles. These include 10x Genomics, Agilent Technologies Inc., Bio-Rad Laboratories Inc., BioSpyder, Inc., CD Genomics, Charles River Laboratories International, Inc., Danaher Corporation, DiaSorin S.p.A., Eurofins Scientific SE, F. Hoffmann-La Roche Ltd., Illumina Inc., Inotiv, Inc., LGC Limited, Merck KGaA, Meridian Bioscience, Inc., NanoString Technologies Inc., New England Biolab, Oxford Gene Technology IP Limited, Oxford Nanopore Technologies plc, Promega Corporation, QIAGEN N.V., Revvity, Inc., Standard BioTools, Takara Bio, Inc., Thermo Fisher Scientific Inc, and Zymo Research Corporation.

Market Segmentation & Coverage

This research report categorizes the Gene Expression Analysis Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Offering, market is studied across Instruments, Reagents & Consumables, and Services. The Instruments is further studied across Microarray Scanners, Next-generation Sequencing (NGS) Platforms, and PCR. The Reagents & Consumables is further studied across Assays & Kits, DNA Microarray, and Enzymes.
  • Based on Application, market is studied across Clinical Diagnostics and Drug Discovery & Development.
  • Based on End-user, market is studied across Academic & Research Institutions, Diagnostic Laboratories, and Pharmaceutical & Biotechnology Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of chronic diseases
      • 5.1.1.2. Increasing preference for gene-based diagnostics
      • 5.1.1.3. Growing advancements in gene editing technology, sequencing, and bioinformatics
    • 5.1.2. Restraints
      • 5.1.2.1. Lack of skilled labor and expenses associated with the instruments and consumables
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing focus on precision oncology
      • 5.1.3.2. Rising need for customized medicine
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns associated with the interpretation of data
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Offering: Growing adoption of advanced instruments with specificity and scalability
    • 5.2.2. Application: Rising significance of gene expression analysis in streamlining the identification of drug targets
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Gene Expression Analysis Market, by Offering

  • 6.1. Introduction
  • 6.2. Instruments
    • 6.2.1. Microarray Scanners
    • 6.2.2. Next-generation Sequencing (NGS) Platforms
    • 6.2.3. PCR
  • 6.3. Reagents & Consumables
    • 6.3.1. Assays & Kits
    • 6.3.2. DNA Microarray
    • 6.3.3. Enzymes
  • 6.4. Services

7. Gene Expression Analysis Market, by Application

  • 7.1. Introduction
  • 7.2. Clinical Diagnostics
  • 7.3. Drug Discovery & Development

8. Gene Expression Analysis Market, by End-user

  • 8.1. Introduction
  • 8.2. Academic & Research Institutions
  • 8.3. Diagnostic Laboratories
  • 8.4. Pharmaceutical & Biotechnology Companies

9. Americas Gene Expression Analysis Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Gene Expression Analysis Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Gene Expression Analysis Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Thermo Fisher Scientific Launched the Invitrogen TaqMan Cells-to-CT Express Kit for Streamlined RNA Processing
    • 12.3.2. Tempus launched Tempus xR, a standalone RNA Sequencing Test
    • 12.3.3. QIAGEN Launched Enhanced QIAGEN CLC Genomics Workbench Premium
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 10x Genomics
  • 2. Agilent Technologies Inc.
  • 3. Bio-Rad Laboratories Inc.
  • 4. BioSpyder, Inc.
  • 5. CD Genomics
  • 6. Charles River Laboratories International, Inc.
  • 7. Danaher Corporation
  • 8. DiaSorin S.p.A.
  • 9. Eurofins Scientific SE
  • 10. F. Hoffmann-La Roche Ltd.
  • 11. Illumina Inc.
  • 12. Inotiv, Inc.
  • 13. LGC Limited
  • 14. Merck KGaA
  • 15. Meridian Bioscience, Inc.
  • 16. NanoString Technologies Inc.
  • 17. New England Biolab
  • 18. Oxford Gene Technology IP Limited
  • 19. Oxford Nanopore Technologies plc
  • 20. Promega Corporation
  • 21. QIAGEN N.V.
  • 22. Revvity, Inc.
  • 23. Standard BioTools
  • 24. Takara Bio, Inc.
  • 25. Thermo Fisher Scientific Inc
  • 26. Zymo Research Corporation

LIST OF FIGURES

  • FIGURE 1. GENE EXPRESSION ANALYSIS MARKET RESEARCH PROCESS
  • FIGURE 2. GENE EXPRESSION ANALYSIS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL GENE EXPRESSION ANALYSIS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL GENE EXPRESSION ANALYSIS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL GENE EXPRESSION ANALYSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS GENE EXPRESSION ANALYSIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS GENE EXPRESSION ANALYSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES GENE EXPRESSION ANALYSIS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES GENE EXPRESSION ANALYSIS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC GENE EXPRESSION ANALYSIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC GENE EXPRESSION ANALYSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA GENE EXPRESSION ANALYSIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA GENE EXPRESSION ANALYSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. GENE EXPRESSION ANALYSIS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. GENE EXPRESSION ANALYSIS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. GENE EXPRESSION ANALYSIS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL GENE EXPRESSION ANALYSIS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL GENE EXPRESSION ANALYSIS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL GENE EXPRESSION ANALYSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. GENE EXPRESSION ANALYSIS MARKET DYNAMICS
  • TABLE 7. GLOBAL GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL GENE EXPRESSION ANALYSIS MARKET SIZE, BY MICROARRAY SCANNERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL GENE EXPRESSION ANALYSIS MARKET SIZE, BY NEXT-GENERATION SEQUENCING (NGS) PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL GENE EXPRESSION ANALYSIS MARKET SIZE, BY PCR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL GENE EXPRESSION ANALYSIS MARKET SIZE, BY ASSAYS & KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL GENE EXPRESSION ANALYSIS MARKET SIZE, BY DNA MICROARRAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL GENE EXPRESSION ANALYSIS MARKET SIZE, BY ENZYMES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL GENE EXPRESSION ANALYSIS MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL GENE EXPRESSION ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL GENE EXPRESSION ANALYSIS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL GENE EXPRESSION ANALYSIS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL GENE EXPRESSION ANALYSIS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL GENE EXPRESSION ANALYSIS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS GENE EXPRESSION ANALYSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES GENE EXPRESSION ANALYSIS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC GENE EXPRESSION ANALYSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 64. AUSTRALIA GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. CHINA GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. INDIA GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. INDONESIA GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. JAPAN GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 85. JAPAN GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. MALAYSIA GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 90. MALAYSIA GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. PHILIPPINES GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 95. PHILIPPINES GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. SINGAPORE GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 100. SINGAPORE GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. SOUTH KOREA GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 105. SOUTH KOREA GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 109. TAIWAN GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 110. TAIWAN GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. THAILAND GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 115. THAILAND GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. VIETNAM GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 120. VIETNAM GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA GENE EXPRESSION ANALYSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 130. DENMARK GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 131. DENMARK GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 135. EGYPT GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 136. EGYPT GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. FINLAND GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 141. FINLAND GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 145. FRANCE GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 146. FRANCE GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 150. GERMANY GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 151. GERMANY GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 155. ISRAEL GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 156. ISRAEL GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 160. ITALY GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 161. ITALY GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 165. NETHERLANDS GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 166. NETHERLANDS GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 170. NIGERIA GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 171. NIGERIA GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 175. NORWAY GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 176. NORWAY GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 180. POLAND GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 181. POLAND GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 185. QATAR GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 186. QATAR GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 190. RUSSIA GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 191. RUSSIA GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 195. SAUDI ARABIA GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 196. SAUDI ARABIA GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 200. SOUTH AFRICA GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH AFRICA GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 205. SPAIN GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 206. SPAIN GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 210. SWEDEN GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 211. SWEDEN GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 215. SWITZERLAND GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 216. SWITZERLAND GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 220. TURKEY GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 221. TURKEY GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 225. UNITED ARAB EMIRATES GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED ARAB EMIRATES GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED KINGDOM GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 235. GENE EXPRESSION ANALYSIS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 236. GENE EXPRESSION ANALYSIS MARKET, FPNV POSITIONING MATRIX, 2023